Agents For The Control Of Parasites On Animals
    2.
    发明申请
    Agents For The Control Of Parasites On Animals 有权
    用于控制动物寄生虫的代理

    公开(公告)号:US20150038537A1

    公开(公告)日:2015-02-05

    申请号:US14128773

    申请日:2012-06-28

    摘要: The invention relates to agents for the control of parasites on animals, comprising an active substance from the group of the phenylpyrazoles and vitamin E or a derivative thereof, such as particularly vitamin E acetate, as well as optionally a further active substance from the group of the pyrethroids and/or optionally additionally further active and/or auxiliary substances. In particular, the invention relates to the use of such agents for the control of ectoparasites such as, in particular, fleas, ticks and sand flies in pets such as, in particular, in dogs, cats and ferrets.

    摘要翻译: 本发明涉及用于控制动物寄生虫的试剂,其包含苯基吡唑和维生素E或其衍生物,特别是维生素E乙酸酯的活性物质,以及任选的另一活性物质 拟除虫菊酯和/或任选地另外的活性和/或辅助物质。 特别地,本发明涉及这种药剂用于控制外来寄生虫,例如特别是宠物中的跳蚤,蜱和沙蝇,特别是在狗,猫和雪貂中的控制。

    Novel Isocyanate And Isothiocyanate Compounds For Cancer Treatment
    3.
    发明申请
    Novel Isocyanate And Isothiocyanate Compounds For Cancer Treatment 有权
    新型异氰酸酯和异硫氰酸酯化合物用于癌症治疗

    公开(公告)号:US20140228419A1

    公开(公告)日:2014-08-14

    申请号:US14346744

    申请日:2012-09-18

    摘要: The present invention relates to novel isocyanate and isothiocyanate compounds, to pharmaceutical compositions comprising them, and to the use thereof in the treatment of cancer diseases in humans and animals. The novel isocyanate and isothiocyanate compounds are distinguished, as compared with the known isocyanate and isothiocyanate compounds, by improved therapeutical breadth, i.e. fewer side effects while having high anti-tumor activity.

    摘要翻译: 本发明涉及新颖的异氰酸酯和异硫氰酸酯化合物,包含它们的药物组合物,以及其在治疗人和动物中的癌症疾病中的用途。 与已知的异氰酸酯和异硫氰酸酯化合物相比,新型异氰酸酯和异硫氰酸酯化合物通过改善的治疗范围,即具有较高抗肿瘤活性的副作用较小。

    Novel Triazene Compounds For The Treatment Of Cancer
    4.
    发明申请
    Novel Triazene Compounds For The Treatment Of Cancer 失效
    新型三氮烯化合物治疗癌症

    公开(公告)号:US20120028927A1

    公开(公告)日:2012-02-02

    申请号:US13205831

    申请日:2011-08-09

    摘要: The present invention relates to novel triazene compounds, to a process for their preparation, to pharmaceutical compositions comprising them, and to the use thereof in the treatment of cancer diseases in humans. The novel triazene compounds are distinguished, as compared with the known triazene compounds, by improved activity while at the same time having reduced toxicity, that is to say by fewer side-effects.

    摘要翻译: 本发明涉及新的三氮烯化合物,其制备方法,包含它们的药物组合物及其在治疗人类癌症疾病中的用途。 与已知的三氮烯化合物相比,新的三氮烯化合物通过改善活性而同时具有降低的毒性,也就是说副作用较少。

    Novel Triazene Compounds For The Treatment Of Cancer
    6.
    发明申请
    Novel Triazene Compounds For The Treatment Of Cancer 有权
    新型三氮烯化合物治疗癌症

    公开(公告)号:US20100234327A1

    公开(公告)日:2010-09-16

    申请号:US12296475

    申请日:2008-07-03

    摘要: The present invention relates to novel triazene compounds, to a process for their preparation, to pharmaceutical compositions comprising them, and to the use thereof in the treatment of cancer diseases in humans. The novel triazene compounds are distinguished, as compared with the known triazene compounds, by improved activity while at the same time having reduced toxicity, that is to say by fewer side-effects.

    摘要翻译: 本发明涉及新的三氮烯化合物,其制备方法,包含它们的药物组合物及其在治疗人类癌症疾病中的用途。 与已知的三氮烯化合物相比,新的三氮烯化合物通过改善活性而同时具有降低的毒性,也就是说副作用较少。